James F. Donohue, MD - Contemporary Management of COPD: A Focus on Comprehensive Approaches to Improve Outcomes in Underserved Communities
Contemporary Management of COPD: A Focus on Comprehensive Approaches to Improve Outcomes in Underserved Communities (Source: PeerView CME/CE Audio Podcast - Primary Care)
Source: PeerView CME/CE Audio Podcast - Primary Care - November 13, 2013 Category: Primary Care Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Integrated disease management interventions for patients with chronic obstructive pulmonary disease (Dutch version)
Er is steeds meer belangstelling voor de effectiviteit van multidisciplinaire zorgprogramma’s voor patiënten met een chronische aandoening, zoals patiënten met COPD. Luister naar deze podcast waarin Annemarije Kruis, huisarts in opleiding en onderzoeker van het Leids Universitair Medisch Centrum, de resultaten beschrijft van de in oktober 2013 verschenen Cochrane review naar de effectiviteit van geïntegreerde zorgprogramma’s voor COPD patiënten.This podcast also available in: read more (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - November 4, 2013 Category: Journals (General) Authors: The Cochrane Collaboration Tags: Issue 10 to 12, October to December 2013 Source Type: podcasts

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Phosphodiesterase 4 inhibitors are a new class of oral medicines for treating chronic obstructive pulmonary disease, and the first Cochrane Review was published in May 2011. Jimmy Chong (left), Phillippa Poole (right) and Bonnie Leung from New Zealand, have updated this in November 2013. Jimmy summarises the latest evidence in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - November 1, 2013 Category: Journals (General) Authors: Cochrane Source Type: podcasts

Integrated disease management interventions for patients with chronic obstructive pulmonary disease
There is increasing interest in cross disciplinary, team approach to helping patients with a chronic condition. This is true in chronic obstructive pulmonary disease, and, in this Evidence Pod, Annemarije Kruis, a general practice trainee at Leiden University in the Netherlands, describes the October 2013 Cochrane Review of research done to date.This podcast also available in: read more (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 29, 2013 Category: Journals (General) Authors: The Cochrane Collaboration Tags: Issue 10 to 12, October to December 2013 Source Type: podcasts

Long-acting beta2-agonists for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease is a common condition and causes the death of millions of people worldwide every year, and the Cochrane Airways Group has already produced several reviews. In October 2013, their collection has been added to with a review of the effects of long-acting beta-agonists. The lead author, Kayleigh Kew from St George’s Hospital in London England, tells us more. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 29, 2013 Category: Journals (General) Authors: The Cochrane Collaboration Tags: Issue 10 to 12, October to December 2013 Source Type: podcasts

Integrated disease management interventions for patients with chronic obstructive pulmonary disease
There is increasing interest in cross disciplinary, team approach to helping patients with a chronic condition. This is true in chronic obstructive pulmonary disease, and, in this Evidence Pod, Annemarije Kruis, a general practice trainee at Leiden University in the Netherlands, describes the October 2013 Cochrane Review of research done to date. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 1, 2013 Category: Journals (General) Authors: Cochrane Source Type: podcasts

Long-acting beta2-agonists for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease is a common condition and causes the death of millions of people worldwide every year, and the Cochrane Airways Group has already produced several reviews. In October 2013, their collection has been added to with a review of the effects of long-acting beta-agonists. The lead author, Kayleigh Kew from St George’s Hospital in London England, tells us more. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - October 1, 2013 Category: Journals (General) Authors: Cochrane Source Type: podcasts